Nanocrystal News and Research

RSS

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Janssen-Cilag has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency for paliperidone palmitate for the treatment of Schizophrenia.

4 Dec 2009

Elan announces fiscal 2009 third-quarter results

Elan Corporation, plc today reported its third quarter 2009 financial results.

21 Oct 2009

Bio-friendly nanocrystals allow study of biomolecules one at a time

Researchers at the U.S. Department of Energy's (DOE) Lawrence Berkeley National Laboratory have created bright, stable and bio-friendly nanocrystals that act as individual investigators of activity within a cell.

17 Jun 2009

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals' proprietary nebulized formulation of budesonide.

21 Dec 2008

New method for detecting HER2 breast cancer

Generations of mothers have served up chicken soup to remedy the common cold, but now the therapeutic fowl may find use in diagnosis as well.

21 Feb 2008

Nanocrystal research for cellulose drug delivery

Maren Roman is taking nanocrystal research to a new level that may lead to a new generation of vaccines and better computer printer ink.

2 Apr 2007

Drug delivery system that consists of nanocrystals of a hydrophobic drug

The problem of efficiently delivering drugs, especially those that are hydrophobic or water-repellant, to tumors or other disease sites has long challenged scientists to develop innovative delivery systems that keep these drugs intact until reaching their targets.

8 Mar 2007

Nanoparticles advance photodynamic therapy to kill tumor cells

Photodynamic therapy (PDT) is a powerful approach for destroying tumors, one that uses light and a light-sensitive chemical to rapidly kill cells.

20 Feb 2007

Bright quantum dots help basic cancer biology studies

Though there is little doubt that nanoscale devices are going to play a critical role in improving cancer detection and treatment over the next five to ten years, nanoparticles are already having a major impact on the way that cancer biologists study the processes that go awry within malignant and metastatic cells.

5 Feb 2007

Aptamer-capped nanocrystal quantum dots

Quantum dots, used increasingly as bright fluorescent markers in basic research and diagnostic assays, must be coated, or capped, with one of a wide variety of organic molecules in order to stabilize these nanocrystals and prevent them from aggregating when added to water.

18 Dec 2006

Nanocrystal News and Research

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Elan announces fiscal 2009 third-quarter results

Bio-friendly nanocrystals allow study of biomolecules one at a time

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

New method for detecting HER2 breast cancer

Nanocrystal research for cellulose drug delivery

Drug delivery system that consists of nanocrystals of a hydrophobic drug

Nanoparticles advance photodynamic therapy to kill tumor cells

Bright quantum dots help basic cancer biology studies

Aptamer-capped nanocrystal quantum dots

Nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009

Emerging nanomedicine technologies could dramatically transform medical science

Nanotechnology-based applications are accelerating the development of nanomedicine

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Latest News